Examination Report |
1 | TM-1 | 25 Jun 2014 |
2 | Reply to Exam Report (MIS-R) | 04 May 2017 |
3 | Reply to Exam Report (MIS-R) | 08 May 2017 |
4 | Reply to Exam Report (MIS-R) | 08 May 2017 |
5 | Reply to Exam Report (MIS-R) | 08 May 2017 |
6 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 27 Mar 2018 |
7 | Letter of Withdrawal | 09 May 2018 |
1 | Dispatching of Examination Report for : 2762123 | 2940172 | 1506143 | 28 Jan 2016 |
2 | Dispatching of Examination Report for : 2762123 | 2940173 | 1506143 | 28 Jan 2016 |
3 | Abandoned Order for Application No 2762123 | 3412898 | 1781336 | 31 Mar 2016 |
4 | Hearing Notice (Show Cause) | 5928860 | 2672899 | 20 Feb 2018 |
5 | Hearing Notice (Adjourned) | 6194514 | 2792328 | 09 Apr 2018 |
6 | Tribunal Withdrawn Notice for : 2762123 | 6325368 | 2878804 | 09 May 2018 |
Ultace was applied on 25 June 2014.
Trademark application was filed by MACLEODS PHARMACEUTICALS.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Withdrawn.
Listed application Id of Ultace is 2762123.
Trademark attorney of the Ultace is Singh & Singh Law Firm Llp.
Ultace is a DEVICE as per IP India data.